Quotes for DanCann Pharma A/S
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Jeppe Krog Rasmussen
Chairperson of the Board
- Carsten Trads
Board
- Jeppe Krog Rasmussen
- Christian Carlsen
- Jes Lunde
DanCann Pharma A/S
DanCann Pharma is a Danish pharmaceutical company focused on the discovery, development, manufacture and commercialization of medical cannabis and cannabinoid-based pharmaceuticals. The company manufactures and distributes prescription and over-the-counter pharmaceuticals, primarily focused on pain patients for the treatment of chronic diseases and pain conditions. DanCann Pharma was founded in 2018 and is headquartered in Denmark.
News
- DanCann Pharma A/S: Delivers Q2-2025 Highlights
- DanCann Pharma A/S shares supplementary details of the obtained bridge loan
- DanCann Pharma A/S signs a conditional sales agreement for the sale of manufacturing site (BP1), secures bridge financing, and launches new strategy, Maturity2028
- DanCann Pharma A/S: Delivers Q1-2025 Highlights – Expands Prescription (Rx) Portfolio, Eyes Consumer Health Market Entry (OTC)
- DanCann Pharma A/S: Præsenterer højdepunkter fra 1. kvartal 2025 – Udvider receptportefølje (Rx) og forbereder indtræden på markedet for håndkøbsprodukter (OTC)
News agencies
- Finwire: Dancann Pharma ökar förlusten, "fortsatt press på pris och volym"
- Finwire: Dancann Pharma säljer produktionsanläggning och säkrar bryggfinansiering
- Finwire: Dancann Pharma får regulatoriskt godkännande för två nya cannabisprodukter
- Finwire: Dancann Pharma ingår partnerskap med Tetra Pharm Technologies
- Finwire: Handeln i Dancann Pharmas aktie återupptas
Analysis
- Carlsquare: Dancann Pharma Kv2 2022: Företrädesemission för att nå Break-even - Carlsquare
- Carlsquare: Dancann Pharma: Bygger pipeline inför lansering - Carlsquare
- Carlsquare: Dancann Pharma: Stärker framtida pipeline med minst 37 miljoner kronor - Carlsquare
- Carlsquare: Dancann Pharma: Startskottet på ny era? - Carlsquare
- Carlsquare: Dancann Pharma: Ljusare utsikter än någonsin tidigare - Carlsquare
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| JEQ Capital AB | 10,42 | 10,42 | 2024-11-25 |
| Robert Burén | 4,20 | 4,20 | 2024-11-25 |
| Niklas Estensson | 4,20 | 4,20 | 2024-11-25 |
| Alexander Schoeneck | 3,83 | 3,83 | 2024-11-25 |
| Erik Lundin | 3,15 | 3,15 | 2024-11-25 |
| Love Carlsson | 2,52 | 2,52 | 2024-11-25 |
| Johan Alexander Kangas | 2,52 | 2,52 | 2024-11-25 |
| Nils Berg | 2,52 | 2,52 | 2024-11-25 |
| Östen Carlssson | 2,10 | 2,10 | 2024-11-25 |
| Jonas Hagberg med bolag | 2,10 | 2,10 | 2024-11-25 |
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2025-10-27 Delårsrapport 2025-Q3
Annual reports, prospectus etc.
- 2025-04-07 Annual Report 2024
- 2024-05-24 Memorandum 2024
- 2024-05-15 Annual Report 2023
- 2023-05-12 Annual Report 2022
- 2022-11-04 Prospectus supplement 2022
- 2022-10-24 Prospectus 2022
- Show More
- 2022-04-13 Annual Report 2021
- 2022-04-13 Auditors report 2021
- 2021-04-07 Annual Report 2020
- 2020-10-09 Teaser SE 2020
- 2020-10-09 Teaser DK 2020
- 2020-10-02 Prospekt 2020
- Close